PDB Short entry for 2JJ3 HEADER TRANSCRIPTION 03-JUL-07 2JJ3 TITLE ESTROGEN RECEPTOR BETA LIGAND BINDING DOMAIN IN COMPLEX TITLE 2 WITH A BENZOPYRAN AGONIST COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR BETA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND-BINDING DOMAIN, RESIDUES 256-505; COMPND 5 SYNONYM: ER-BETA; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS PHOSPHORYLATION, STEROID-BINDING, NUCLEAR RECEPTOR, KEYWDS 2 TRANSCRIPTION REGULATION, ALTERNATIVE SPLICING, LIGAND KEYWDS 3 BINDING DOMAIN, ZINC, NUCLEUS, RECEPTOR, ZINC-FINGER, KEYWDS 4 DNA-BINDING, TRANSCRIPTION, METAL-BINDING, LIPID-BINDING EXPDTA X-RAY DIFFRACTION AUTHOR B.H.NORMAN,T.I.RICHARDSON,J.A.DODGE,L.A.PFEIFER,G.L.DURST, AUTHOR 2 Y.WANG,J.D.DURBIN,V.KRISHNAN,S.R.DINN,S.LIU,J.E.REILLY, AUTHOR 3 K.T.RYTER REVDAT 3 24-FEB-09 2JJ3 1 VERSN REVDAT 2 04-SEP-07 2JJ3 1 JRNL REVDAT 1 07-AUG-07 2JJ3 0 JRNL AUTH B.H.NORMAN,T.I.RICHARDSON,J.A.DODGE,L.A.PFEIFER, JRNL AUTH 2 G.L.DURST,Y.WANG,J.D.DURBIN,V.KRISHNAN,S.R.DINN, JRNL AUTH 3 S.LIU,J.E.REILLY,K.T.RYTER JRNL TITL BENZOPYRANS AS SELECTIVE ESTROGEN RECEPTOR BETA JRNL TITL 2 AGONISTS (SERBAS). PART 4: FUNCTIONALIZATION OF JRNL TITL 3 THE BENZOPYRAN A-RING. JRNL REF BIOORG.MED.CHEM.LETT. V. 17 5082 2007 JRNL REFN ISSN 0960-894X JRNL PMID 17662603 JRNL DOI 10.1016/J.BMCL.2007.07.009 REMARK 2 REMARK 2 RESOLUTION. 2.28 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2002 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.28 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.10 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.0 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 25114 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.235 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.0 REMARK 3 FREE R VALUE TEST SET COUNT : 1012 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.28 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.42 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.8 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.295 REMARK 3 BIN FREE R VALUE : 0.325 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.7 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.027 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3520 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 48 REMARK 3 SOLVENT ATOMS : 62 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 39.4 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 48.4 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.79 REMARK 3 B22 (A**2) : 0.79 REMARK 3 B33 (A**2) : -1.58 REMARK 3 B12 (A**2) : 2.68 REMARK 3 B13 (A**2) : 0.00 REMARK 3 B23 (A**2) : 0.00 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM SIGMAA (A) : 0.30 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.36 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.36 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.2 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 19.4 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.81 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.46 ; 1.50 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.41 ; 2.00 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.34 ; 2.00 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.52 ; 2.50 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.377125 REMARK 3 BSOL : 54.4724 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : LIG.PAR REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2JJ3 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-JUL-07. REMARK 100 THE PDBE ID CODE IS EBI-33111. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-JUN-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 31-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25114 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.28 REMARK 200 RESOLUTION RANGE LOW (A) : 33.10 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.2 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 200 DATA REDUNDANCY : 5.7 REMARK 200 R MERGE (I) : 0.09 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.90 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.28 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.40 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.9 REMARK 200 R MERGE FOR SHELL (I) : 0.77 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.20 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.21 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.84 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2M NACL, 9% PEG 6,000, 100MM TRIS REMARK 280 PH 8.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 82.96900 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 165.93800 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 124.45350 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 207.42250 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 41.48450 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 3590 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23510 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -27.1 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 249 REMARK 465 HIS A 250 REMARK 465 HIS A 251 REMARK 465 HIS A 252 REMARK 465 HIS A 253 REMARK 465 HIS A 254 REMARK 465 HIS A 255 REMARK 465 ARG A 256 REMARK 465 GLU A 257 REMARK 465 LEU A 258 REMARK 465 LEU A 259 REMARK 465 LEU A 260 REMARK 465 SER A 286 REMARK 465 ALA A 287 REMARK 465 PRO A 288 REMARK 465 PHE A 289 REMARK 465 THR A 290 REMARK 465 GLU A 291 REMARK 465 THR A 415 REMARK 465 ALA A 416 REMARK 465 THR A 417 REMARK 465 GLN A 418 REMARK 465 ASP A 419 REMARK 465 ALA A 420 REMARK 465 ASP A 421 REMARK 465 CYS A 481 REMARK 465 LYS A 482 REMARK 465 LEU A 500 REMARK 465 ARG A 501 REMARK 465 GLY A 502 REMARK 465 CYS A 503 REMARK 465 LYS A 504 REMARK 465 SER A 505 REMARK 465 MET B 249 REMARK 465 HIS B 250 REMARK 465 HIS B 251 REMARK 465 HIS B 252 REMARK 465 HIS B 253 REMARK 465 HIS B 254 REMARK 465 HIS B 255 REMARK 465 ARG B 256 REMARK 465 GLU B 257 REMARK 465 LEU B 258 REMARK 465 LEU B 259 REMARK 465 SER B 286 REMARK 465 ALA B 287 REMARK 465 PRO B 288 REMARK 465 PHE B 289 REMARK 465 THR B 290 REMARK 465 GLU B 291 REMARK 465 THR B 415 REMARK 465 ALA B 416 REMARK 465 THR B 417 REMARK 465 GLN B 418 REMARK 465 ASP B 419 REMARK 465 ALA B 420 REMARK 465 ASP B 421 REMARK 465 CYS B 481 REMARK 465 LYS B 482 REMARK 465 GLY B 502 REMARK 465 CYS B 503 REMARK 465 LYS B 504 REMARK 465 SER B 505 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 261 CG OD1 OD2 REMARK 470 ARG A 284 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 424 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 480 CG CD CE NZ REMARK 470 VAL A 499 CA C O CB CG1 CG2 REMARK 470 ARG B 284 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 424 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 480 CG CD CE NZ REMARK 470 ARG B 501 CA C O CB CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 REMARK 500 O PRO A 358 O PRO B 358 6545 2.02 REMARK 500 O PRO B 358 O PRO A 358 5664 2.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 265 -69.33 -27.77 REMARK 500 SER A 283 67.92 61.09 REMARK 500 LEU A 360 81.00 -152.10 REMARK 500 PRO A 412 9.96 -62.50 REMARK 500 SER B 283 74.44 54.35 REMARK 500 CYS B 369 -72.67 -50.82 REMARK 500 PRO B 412 6.38 -66.19 REMARK 500 LYS B 443 5.04 -69.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE JJ3 A1499 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE JJ3 B1501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1X7B RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA REMARK 900 COMPLEXED WITHERB-041 REMARK 900 RELATED ID: 1X7J RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA REMARK 900 COMPLEXED WITHGENISTEIN REMARK 900 RELATED ID: 1YY4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA REMARK 900 COMPLEXED WITH1-CHLORO-6-(4-HYDROXY-PHENYL REMARK 900 )-NAPHTHALEN-2-OL REMARK 900 RELATED ID: 2FSZ RELATED DB: PDB REMARK 900 A SECOND BINDING SITE FOR HYDROXYTAMOXIFEN REMARK 900 WITHIN THECOACTIVATOR-BINDING GROOVE OF REMARK 900 ESTROGEN RECEPTOR BETA REMARK 900 RELATED ID: 1L2J RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR BETA LIGAND-BINDING REMARK 900 DOMAIN INCOMPLEX WITH (R,R)-5,11-CIS- REMARK 900 DIETHYL-5,6,11,12-TETRAHYDROCHRYSENE-2,8- REMARK 900 DIOL REMARK 900 RELATED ID: 1NDE RELATED DB: PDB REMARK 900 ESTROGEN RECEPTOR BETA WITH SELECTIVE TRIAZINE REMARK 900 MODULATOR REMARK 900 RELATED ID: 1QKM RELATED DB: PDB REMARK 900 HUMAN OESTROGEN RECEPTOR BETA LIGAND-BINDING REMARK 900 DOMAIN IN COMPLEX WITH PARTIAL AGONIST REMARK 900 GENISTEIN REMARK 900 RELATED ID: 1U3Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA REMARK 900 COMPLEXED WITHCL-272 REMARK 900 RELATED ID: 1U3R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA REMARK 900 COMPLEXED WITHWAY-338 REMARK 900 RELATED ID: 1U3S RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA REMARK 900 COMPLEXED WITHWAY-797 REMARK 900 RELATED ID: 1U9E RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA REMARK 900 COMPLEXED WITHWAY-397 REMARK 900 RELATED ID: 1X76 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA REMARK 900 COMPLEXED WITHWAY-697 REMARK 900 RELATED ID: 1X78 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA REMARK 900 COMPLEXED WITHWAY-244 REMARK 900 RELATED ID: 1YYE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA REMARK 900 COMPLEXED WITHWAY-202196 DBREF 2JJ3 A 249 255 PDB 2JJ3 2JJ3 249 255 DBREF 2JJ3 A 256 505 UNP Q92731 ESR2_HUMAN 256 505 DBREF 2JJ3 B 249 255 PDB 2JJ3 2JJ3 249 255 DBREF 2JJ3 B 256 505 UNP Q92731 ESR2_HUMAN 256 505 SEQRES 1 A 257 MET HIS HIS HIS HIS HIS HIS ARG GLU LEU LEU LEU ASP SEQRES 2 A 257 ALA LEU SER PRO GLU GLN LEU VAL LEU THR LEU LEU GLU SEQRES 3 A 257 ALA GLU PRO PRO HIS VAL LEU ILE SER ARG PRO SER ALA SEQRES 4 A 257 PRO PHE THR GLU ALA SER MET MET MET SER LEU THR LYS SEQRES 5 A 257 LEU ALA ASP LYS GLU LEU VAL HIS MET ILE SER TRP ALA SEQRES 6 A 257 LYS LYS ILE PRO GLY PHE VAL GLU LEU SER LEU PHE ASP SEQRES 7 A 257 GLN VAL ARG LEU LEU GLU SER CYS TRP MET GLU VAL LEU SEQRES 8 A 257 MET MET GLY LEU MET TRP ARG SER ILE ASP HIS PRO GLY SEQRES 9 A 257 LYS LEU ILE PHE ALA PRO ASP LEU VAL LEU ASP ARG ASP SEQRES 10 A 257 GLU GLY LYS CYS VAL GLU GLY ILE LEU GLU ILE PHE ASP SEQRES 11 A 257 MET LEU LEU ALA THR THR SER ARG PHE ARG GLU LEU LYS SEQRES 12 A 257 LEU GLN HIS LYS GLU TYR LEU CYS VAL LYS ALA MET ILE SEQRES 13 A 257 LEU LEU ASN SER SER MET TYR PRO LEU VAL THR ALA THR SEQRES 14 A 257 GLN ASP ALA ASP SER SER ARG LYS LEU ALA HIS LEU LEU SEQRES 15 A 257 ASN ALA VAL THR ASP ALA LEU VAL TRP VAL ILE ALA LYS SEQRES 16 A 257 SER GLY ILE SER SER GLN GLN GLN SER MET ARG LEU ALA SEQRES 17 A 257 ASN LEU LEU MET LEU LEU SER HIS VAL ARG HIS ALA SER SEQRES 18 A 257 ASN LYS GLY MET GLU HIS LEU LEU ASN MET LYS CYS LYS SEQRES 19 A 257 ASN VAL VAL PRO VAL TYR ASP LEU LEU LEU GLU MET LEU SEQRES 20 A 257 ASN ALA HIS VAL LEU ARG GLY CYS LYS SER SEQRES 1 B 257 MET HIS HIS HIS HIS HIS HIS ARG GLU LEU LEU LEU ASP SEQRES 2 B 257 ALA LEU SER PRO GLU GLN LEU VAL LEU THR LEU LEU GLU SEQRES 3 B 257 ALA GLU PRO PRO HIS VAL LEU ILE SER ARG PRO SER ALA SEQRES 4 B 257 PRO PHE THR GLU ALA SER MET MET MET SER LEU THR LYS SEQRES 5 B 257 LEU ALA ASP LYS GLU LEU VAL HIS MET ILE SER TRP ALA SEQRES 6 B 257 LYS LYS ILE PRO GLY PHE VAL GLU LEU SER LEU PHE ASP SEQRES 7 B 257 GLN VAL ARG LEU LEU GLU SER CYS TRP MET GLU VAL LEU SEQRES 8 B 257 MET MET GLY LEU MET TRP ARG SER ILE ASP HIS PRO GLY SEQRES 9 B 257 LYS LEU ILE PHE ALA PRO ASP LEU VAL LEU ASP ARG ASP SEQRES 10 B 257 GLU GLY LYS CYS VAL GLU GLY ILE LEU GLU ILE PHE ASP SEQRES 11 B 257 MET LEU LEU ALA THR THR SER ARG PHE ARG GLU LEU LYS SEQRES 12 B 257 LEU GLN HIS LYS GLU TYR LEU CYS VAL LYS ALA MET ILE SEQRES 13 B 257 LEU LEU ASN SER SER MET TYR PRO LEU VAL THR ALA THR SEQRES 14 B 257 GLN ASP ALA ASP SER SER ARG LYS LEU ALA HIS LEU LEU SEQRES 15 B 257 ASN ALA VAL THR ASP ALA LEU VAL TRP VAL ILE ALA LYS SEQRES 16 B 257 SER GLY ILE SER SER GLN GLN GLN SER MET ARG LEU ALA SEQRES 17 B 257 ASN LEU LEU MET LEU LEU SER HIS VAL ARG HIS ALA SER SEQRES 18 B 257 ASN LYS GLY MET GLU HIS LEU LEU ASN MET LYS CYS LYS SEQRES 19 B 257 ASN VAL VAL PRO VAL TYR ASP LEU LEU LEU GLU MET LEU SEQRES 20 B 257 ASN ALA HIS VAL LEU ARG GLY CYS LYS SER HET JJ3 A1499 24 HET JJ3 B1501 24 HETNAM JJ3 (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6- HETNAM 2 JJ3 (METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C] HETNAM 3 JJ3 CHROMEN-8-OL FORMUL 3 JJ3 2(C20 H22 O4) FORMUL 4 HOH *62(H2 O1) HELIX 1 1 SER A 264 GLU A 276 1 13 HELIX 2 2 SER A 293 ILE A 316 1 24 HELIX 3 3 GLY A 318 LEU A 322 5 5 HELIX 4 4 SER A 323 ILE A 348 1 26 HELIX 5 5 ASP A 365 CYS A 369 5 5 HELIX 6 6 GLY A 372 LEU A 390 1 19 HELIX 7 7 GLN A 393 ASN A 407 1 15 HELIX 8 8 MET A 410 VAL A 414 5 5 HELIX 9 9 SER A 422 LYS A 443 1 22 HELIX 10 10 SER A 447 ASN A 478 1 32 HELIX 11 11 PRO A 486 HIS A 498 1 13 HELIX 12 12 LEU B 260 LEU B 263 5 4 HELIX 13 13 SER B 264 GLU B 276 1 13 HELIX 14 14 ALA B 292 LYS B 315 1 24 HELIX 15 15 GLY B 318 LEU B 322 5 5 HELIX 16 16 SER B 323 ILE B 348 1 26 HELIX 17 17 ASP B 365 CYS B 369 5 5 HELIX 18 18 GLY B 372 LEU B 390 1 19 HELIX 19 19 GLN B 393 ASN B 407 1 15 HELIX 20 20 MET B 410 VAL B 414 5 5 HELIX 21 21 SER B 422 LYS B 443 1 22 HELIX 22 22 SER B 447 ASN B 478 1 32 HELIX 23 23 PRO B 486 LEU B 500 1 15 SHEET 1 AA 2 LYS A 353 ALA A 357 0 SHEET 2 AA 2 LEU A 360 ASP A 363 -1 O LEU A 360 N PHE A 356 SHEET 1 BA 2 LYS B 353 ALA B 357 0 SHEET 2 BA 2 LEU B 360 ASP B 363 -1 O LEU B 360 N PHE B 356 SITE 1 AC1 14 MET A 295 THR A 299 ALA A 302 GLU A 305 SITE 2 AC1 14 LEU A 339 ARG A 346 PHE A 356 ILE A 376 SITE 3 AC1 14 PHE A 377 GLY A 472 HIS A 475 LEU A 476 SITE 4 AC1 14 VAL A 487 HOH A2005 SITE 1 AC2 12 MET B 295 THR B 299 ALA B 302 GLU B 305 SITE 2 AC2 12 ARG B 346 PHE B 356 PHE B 377 GLY B 472 SITE 3 AC2 12 HIS B 475 LEU B 476 VAL B 487 HOH B2012 CRYST1 63.409 63.409 248.907 90.00 90.00 120.00 P 61 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015771 0.009105 0.000000 0.00000 SCALE2 0.000000 0.018210 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004018 0.00000